USPTO Deadlines
Next Deadline
48 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200310)
Due Date
March 10, 2026
Grace Period Ends
September 10, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 8, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Apr 22, 2020 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Apr 22, 2020 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Apr 9, 2020 | GPAR | P | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | Loading... |
| Mar 10, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 4, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Dec 24, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 18, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Dec 4, 2019 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 21, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 19, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 13, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 7, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 042
Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional T cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ULTRA SCAPE
Classification
International Classes
042